Home

בדרך כלל נייד לבד teva israel pharmaceuticals ms drug משפטי יוגורט לתשע

Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. |  Barron's
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's

Teva beats first-quarter expectations but still has the same old problems -  MarketWatch
Teva beats first-quarter expectations but still has the same old problems - MarketWatch

Israel's Teva seeks to acquire drug manufacturer Mylan for $40 billion -  The 5 Towns Jewish Times
Israel's Teva seeks to acquire drug manufacturer Mylan for $40 billion - The 5 Towns Jewish Times

Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals - Wikipedia

Biogen, Teva benefit as payers ease up on multiple sclerosis meddling:  analyst | Fierce Pharma
Biogen, Teva benefit as payers ease up on multiple sclerosis meddling: analyst | Fierce Pharma

Israel's Teva gives upbeat outlook as restructuring proceeds | AP News
Israel's Teva gives upbeat outlook as restructuring proceeds | AP News

Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of  Israel
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel

What are the implications of a generic Teva MS drug? Here's what the wags  say - STAT
What are the implications of a generic Teva MS drug? Here's what the wags say - STAT

EU antitrust authorities launch probe of Teva over Copaxone drug | The  Times of Israel
EU antitrust authorities launch probe of Teva over Copaxone drug | The Times of Israel

After Multiple Failures, Teva Returns Laquinimod Rights to Active Biotech |  BioSpace
After Multiple Failures, Teva Returns Laquinimod Rights to Active Biotech | BioSpace

Teva Pharmaceutical Stock: Stuck In A Cycle Of Hope And Disappointment |  Seeking Alpha
Teva Pharmaceutical Stock: Stuck In A Cycle Of Hope And Disappointment | Seeking Alpha

A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New  York Times
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times

Teva faces class-action lawsuit over US antitrust probe into price-fixing |  The Times of Israel
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel

Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement -  The New York Times
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times

Israeli drug company Teva reaches $4.3 billion settlement in US opioid  lawsuits | The Times of Israel
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel

Teva stock drops on guidance, manufacturing problems - MarketWatch
Teva stock drops on guidance, manufacturing problems - MarketWatch

Brand-name drug group accepts Teva, a maker of generics - The Boston Globe
Brand-name drug group accepts Teva, a maker of generics - The Boston Globe

Analysts Split Over Buffett's Backing of Teva Pharma | BioSpace
Analysts Split Over Buffett's Backing of Teva Pharma | BioSpace

Teva abused patent system and spread misinformation about a Copaxone rival,  European officials say
Teva abused patent system and spread misinformation about a Copaxone rival, European officials say

Teva Pharmaceuticals considers laying-off 10,000 workers - The Jerusalem  Post
Teva Pharmaceuticals considers laying-off 10,000 workers - The Jerusalem Post

Teva's CEO Shows He Means Business With Planned 25% Job Cuts - Bloomberg
Teva's CEO Shows He Means Business With Planned 25% Job Cuts - Bloomberg

Supreme Court rules for Teva over MS drug patent | Reuters.com
Supreme Court rules for Teva over MS drug patent | Reuters.com

Teva knocked as competition fears grow for MS drug | Financial Times
Teva knocked as competition fears grow for MS drug | Financial Times

Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals - Wikipedia

U.S. Supreme Court rules for Teva over multiple sclerosis drug patent |  Business Insurance
U.S. Supreme Court rules for Teva over multiple sclerosis drug patent | Business Insurance

Suffering from missteps, drugmaker Teva struggles to heal own ills | The  Times of Israel
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel

Teva Pharmaceutical set for major layoffs in Israel, US: Report, Health  News, ET HealthWorld
Teva Pharmaceutical set for major layoffs in Israel, US: Report, Health News, ET HealthWorld

Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug  Manufacturing | Ctech
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech